Blog Archives

Top 5 News Stories: 10/19-10/25

Top 5 logo1) Cubist wins expanded approval for GI drug- Boston Business Journal- October 21, 2013

Cubist Pharmaceuticals Inc. has won an expanded Food and Drug Administration approval for its gastrointestinal surgery drug Entereg.The drug helps speed recovery for patients after bowel resection for benign or malignant colorectal or small bowel disease. Link

2) PerkinElmer opens ‘Center for Innovation’ in Hopkinton- MetroWest Daily News- October 22, 2013

Life sciences company PerkinElmer Inc. held a ribbon-cutting ceremony today for the official opening of its Center for Innovation. Company literature bills the center as a hub of international research and development, as well as a consolidation of manufacturing functions.The center is located at 68 Elm St., one of two PerkinElmer locations, with the other one on Parkwood Drive. Link

3) Dana-Farber to start construction on cancer imaging center in Hub’s Innovation District- Boston Globe- October 23, 2013

Dana-Farber Cancer Institute is planning to celebrate the start of construction for its new Molecular Cancer Imaging Facility with a “sledgehammer” ceremony on the Dana-Farber harbor campus in South Boston’s Innovation District. Link

4) Alexion bags another FDA ‘breakthrough for rare-disease drug- Fierce Biotech- October 24, 2013

Alexion Pharmaceuticals has racked up its second breakthrough therapy designation from the FDA, securing a faster track for an early-phase enzyme-replacement treatment targeting an ultra-rare metabolic disorder. Link

5) Marlborough strives to become a life science industry hub- Boston Globe- October 24, 2013

When developer Jon Delli Priscoli wanted to construct a new building in Marlborough, he spent a few hours driving around Cambridge taking pictures of the sleek, modernistic buildings that make up the face of the science and technology hub. “I made a hybrid of those styles with my own, so that we could have a Cambridge-style building here in Marlborough,” said Delli Priscoli, chief executive officer of First Colony Development. Link

Top 5 News Stories 11/17 – 11/23

1) Shire, Boston Children’s enter research agreement – Mass High Tech  – 11/20/2012

Irish drug giant Shire plc (Nasdaq: SHPG) will pay Boston Children’s Hospital an undisclosed amount under a three-year research agreement intended to find new candidates to treat a range of rare pediatric diseases. Link

2) Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases – Marketwire – 11/20/2012

The Biotech Industry has skyrocketed in 2012 as an increase in the number of new drug approvals has boosted investor optimism within the industry. The iShares Nasdaq Biotechnology Index Fund (IBB) and the SPDR S&P Biotech ETF (XBI) have both gained over 25 percent year-to-date. Link

3) Bristol-Pfizer anticlot drug gets key EU approval – – 11/20/2012

European regulators have approved a crucial new anticlotting drug, Eliquis, for preventing strokes and dangerous clots in the circulatory system, the drug’s makers said Tuesday. Eliquis was approved for use in the 27 European Union countries in patients who have an irregular heartbeat called atrial fibrillation and are at risk for strokes or dangerous clots called systemic embolisms. Link Read the rest of this entry

Top 5 News Stories 6/1-6/8

1. Vertex, Epizyme, Rib-X named best places to work Mass High Tech – 6/4/12

The Scientist magazine’s yearly Best Places to Work awards have often shone a light on New England companies and this year is no exception. Little Cambridge, Mass-based personalized medicine company Epizyme, with 45 employees, nabbed the number 2 spot nationwide, while its neighbor, the much larger Vertex Pharmaceuticals (Nasdaq: VRTX), with 2047 workers, scored the number 5 spot. Link

2. Boston Biotech Industry Takes Center Stage at the 2012 BIO International Convention Market Watch – 6/5/12

The 2012 BIO International Convention will return to Boston, Mass. for the global event for biotechnology, which will take place June 18-21, 2012 at the Boston Convention and Exhibition Center. Link

3. WPI gets $3M NSF grant for biofabrication program Mass High Tech – 6/6/12

Worcester Polytechnic Institute (WPI) has received a five-year, $3 million award from the National Science Foundation (NSF) to launch a graduate program in biofabrication geared toward turning students into innovators.  Link

Read the rest of this entry

New Members

Atreaon, Inc., is a privately held biopharmaceutical company developing a novel engineered protein called Atsttrin, for the treatment of inflammatory diseases such as rheumatoid arthritis. Atreaon recently completed a $20 million Series A financing to support the pre-clinical development of Atsttrin. Link

KeraFAST, Inc, provides “Extraordinary Products…from Extraordinary Scientists” as the next generation of research tools for life science laboratories worldwide. KeraFAST offers an incomparable assortment of unique bioreagents, rare materials, biologicals, solutions, labware and services through its e-commerce catalog. Link

PerkinElmer is taking action to harness the power of insights and transform them into knowledge to deliver innovative, differentiated solutions for our customers. From critical therapeutic and disease research and prenatal screening, to environmental testing and industrial monitoring, we are actively engaged in improving health and advancing quality and longevity of life all around the world. Link

Sirius Analytical offers both instrumentation and CRO services for measurement of pKa, logP/logD, Solubility and Dissolution including detailed customized studies of Solubility, Supersaturation and Dissolution with real-time pH control in formulation excipients and biorelevant media. Link